A Study to evaluate the effect of Siddharthakavachadi Cream in Acne
Phase 3
- Conditions
- Health Condition 1: L709- Acne, unspecified
- Registration Number
- CTRI/2022/09/045166
- Lead Sponsor
- DR PRATHIBHA G
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Female patients aged between 10 and 50 years old.
2.Patients with clinical presentations of Acne
3.Those with grade1 to grade 5 Acne. (Assessed using Acne Global Severity Scale-FDA).
4.Those with mild to severe post acne scarring (Assessed using Global Scale for Acne Scar Severity [SCAR-S])
Exclusion Criteria
1.Patients who are known cases of other skin pathologies.
2.History of taking the anti-acne treatment during the last 4 weeks.
3.Pregnant women
4.Lactating mothers
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Acne grading- Acne Global Severity Scale-FDA <br/ ><br>Severity of Acne-Leeds revised acne grading system <br/ ><br>Severity of post acne scarring-Global Scale for Acne Scar Severity (SCAR-S) <br/ ><br>Pain- Visual Analogue Scale (VAS) <br/ ><br>Itching- 5D Pruritis Scale <br/ ><br>Skin echogenicity, Skin thickness changes, Depth of acne and scar, Oiliness of skin, Pigmentation and vascularity assessment- Dermalab instrument <br/ ><br> <br/ ><br> <br/ ><br> <br/ ><br>Timepoint: Acne grading- Day0, Day11, Day21, Day31, Day61 <br/ ><br>Severity of Acne- Day 0, Day11, Day21, Day31, Day61 <br/ ><br>Severity of Post Acne Scarring- Day0, Day11, Day21, Day31, Day61 <br/ ><br>Pain- Day0, Day11, Day21, Day31, Day61 <br/ ><br>Itching-Day0, Day11, Day21, Day31, Day 61 <br/ ><br>Skin echogenicity, Skin thickness changes, Depth of acne and scar, Oiliness of skin, Pigmentation and vascularity- Day0, Day31, Day61 <br/ ><br>
- Secondary Outcome Measures
Name Time Method ilTimepoint: Nil